Dataset Information

Novel prognostic biomarkers in central neurocytoma

ABSTRACT: Central neurocytomas (CN) are intraventricular brain tumors predominantly occurring in young adults. Although prognosis is usually favorable, tumor recurrence is common, particularly following subtotal resection (STR). Currently, the risk of progression is evaluated using histopathological criteria, such as atypical features and elevated Ki67 proliferation index. However, these markers lack consistent definitions and application. Genome-wide DNA methylation profiles were examined in 136 tumors histologically classified as CN. Clinical and histopathological characteristics were assessed in 93 and 90 cases, and whole-exome sequencing was conducted in 12 cases. Clinical and molecular characteristics were integrated into a survival model to predict progression-free survival (PFS). A diagnosis of CN was epigenetically confirmed in 125 of 136 cases (92%). No DNA methylation subgroups associated with risk were identified, but global DNA hypomethylation emerged as a hallmark feature of CN. Hypomethylation at the FGFR3 locus, accompanied by increased FGFR3 protein expression, was observed in 97% of cases. Exome-sequencing revealed BCR frameshift mutations in 3/12 cases. Gross total resection was associated with significantly improved PFS compared to subtotal resected tumors (STR), while patients undergoing STR benefited from adjuvant radiotherapy (p = 0.00088). Younger patients were identified as having a higher risk of recurrence (p = 0.026). Patient age and treatment strategy were key factors influencing survival outcomes in this cohort. These findings underscore the importance of closer follow-up for younger patients and recommend radiotherapy for STR cases. Furthermore, FGFR3 represents a hallmark feature and potential therapeutic target warranting further investigation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE288337 | GEO | 2025/06/18

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Prospective series of 136 clinical monoclonal B lymphocytosis (cMBL) and 216 chronic lymphocytic leukemia (CLL) Rai 0 patients, were investigated in this study. While the distribution of CD38 and ZAP-70 positivity was similar, IGHV-mutated cases were more frequent among cMBL (P = 0.005). A Cox multivariate analysis on the whole patient cohort showed that cMBL condition was predictive of longer PFS, while CD38 expression and IGHV-unmutated status and CD38 expression correlated significantly with a shorter PFS in cMBL and Rai0-CLL, respectively. Trisomy 12, 11q- and 17p- abnormalities were scanty and of no predictive value in both conditions. Notably, gene and miRNA expression profiling showed no significant differences between cMBL and Rai0-CLL. Furthermore, similar gene and miRNA expression signatures were found in cMBL and Rai0-CLL according to the IGHV gene mutational status: that is, unmutated cases had different signatures from mutated cases, irrespectively of the cMBL or CLL condition. Overall, our study based on a prospective series of patients indicates that no major biological differences exist in cMBL compared to Rai0-CLL, suggesting that this two entities mainly differ for the initial size of the monoclonal cell population which may reflect in the longer time for clonal expansion. This series of microarray experiments contains the gene expression profiles of purified B-cell chronic lymphocytic leukemia (B-CLL) cells obtained from 160 patients (Binet stage A) including 45 cMBL and 115 Rai0-CLL. Peripheral blood mononuclear cells from CLL patients were isolated by Ficoll-Hypaque (Seromed, Biochrom KG, Berlin, Germany) density-gradient centrifugation. For gene and miRNA expression profiling experiments CLL cells were enriched by negative selection with the EasySep-Human B cell enrichment kit without CD43 depletion (Stem Cell Technologies) using the fully automated protocol of immunomagnetic cell separation with RoboSepTM (Stem Cell Technologies).

Dataset Information

Novel prognostic biomarkers in central neurocytoma

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets